When this expertise matters
- A product might be SaMD, but the classification is unclear.
- Commercial claims are developing faster than the evidence plan.
- The team needs UK, EU or US route clarity before fundraising or launch.
Expertise
SaMD regulatory strategy
Classification, intended purpose, claims, evidence planning and route-to-market strategy for software-first medical products.
How it is used
Specialist input, applied at the right moment.
Capability areas
- Classification and intended purpose analysis
- Claims review
- Evidence strategy
- UKCA, CE and FDA route mapping
Typical outputs
- Classification rationale
- Claims and evidence map
- Market access roadmap
Start here
Need this capability on a project?
Neural Vibe can coordinate the right specialist input without making your team manage a fragmented compliance bench.
Book a discovery call